Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
3.050
-0.010 (-0.33%)
At close: Oct 30, 2026, 4:00 PM EDT
3.061
+0.011 (0.34%)
After-hours: Oct 30, 2026, 7:30 PM EDT
Neuphoria Therapeutics Employees
Neuphoria Therapeutics had 1 employees as of June 30, 2026. The number of employees decreased by 7 or 87.50% compared to the previous year. That makes Neuphoria Therapeutics the 44,085th largest employer in the world and 7,286th in the United States.
Employees
1
Change (1Y)
-7
Growth (1Y)
-87.50%
Revenue / Employee
$1,174,165
Profits / Employee
-$13,451,931
Market Cap
16.50M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 1 | -7 | -87.50% | 1 | 0 |
| Jun 30, 2025 | 8 | 0 | - | 7 | 1 |
| Jun 30, 2024 | 8 | - | - | 8 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Karyopharm Therapeutics | 228 |
| Pluri | 113 |
| Seres Therapeutics | 66 |
| Acumen Pharmaceuticals | 61 |
| Kyntra Bio | 34 |
| Jasper Therapeutics | 22 |
| Context Therapeutics | 15 |
| Radiopharm Theranostics | 14 |
NEUP News
- 6 weeks ago - Neuphoria Therapeutics Proxy statement: Proxy filing - Filings
- 6 weeks ago - Neuphoria Therapeutics Proxy statement: Proxy filing - Filings
- 6 weeks ago - Neuphoria Therapeutics Proxy statement: Proxy filing - Filings
- 6 weeks ago - Neuphoria Therapeutics Annual report: Q4 2026 - Filings
- 3 months ago - Neuphoria Therapeutics Proxy statement: Proxy filing - Filings
- 3 months ago - Neuphoria Therapeutics to be acquired by Scancell - TheFly
- 3 months ago - Scancell and Neuphoria Therapeutics Announce Merger Agreement and Financing - GlobeNewsWire
- 4 months ago - Neuphoria Therapeutics confirms merger discussions with Scancell Holdings - TheFly